francesco lo coco

About francesco lo coco

francesco lo coco, With an exceptional h-index of 106 and a recent h-index of 50 (since 2020), a distinguished researcher at Università degli Studi di Roma Tor Vergata, specializes in the field of leucemie, diagnostica molecolare, monitoraggio della malattia minima residua.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (vol 13, 2, 2022)

Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia

Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico‐biological parameters

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants

Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia

francesco lo coco Information

University

Position

Professore Ordinario di Malattie del Sangue

Citations(all)

59098

Citations(since 2020)

19900

Cited By

49407

hIndex(all)

106

hIndex(since 2020)

50

i10Index(all)

380

i10Index(since 2020)

206

Email

University Profile Page

Università degli Studi di Roma Tor Vergata

Google Scholar

View Google Scholar Profile

francesco lo coco Skills & Research Interests

leucemie

diagnostica molecolare

monitoraggio della malattia minima residua

Top articles of francesco lo coco

Title

Journal

Author(s)

Publication Date

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (vol 13, 2, 2022)

Nature Communications

Jayaram Vijayakrishnan

James Studd

Peter Broderick

Ben Kinnersley

Amy Holroyd

...

2019

Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

nature communications

Bhuwan Khatri

Kandice L Tessneer

Astrid Rasmussen

Farhang Aghakhanian

Tove Ragna Reksten

...

2022/10/31

Mutational profile of ZBTB16‐RARA‐positive acute myeloid leukemia

Cancer Medicine

Emiliano Fabiani

Laura Cicconi

Anna Maria Nardozza

Antonio Cristiano

Marianna Rossi

...

2021/6

Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico‐biological parameters

British Journal of Haematology

Carmelo Gurnari

Massimo Breccia

Francesca Di Giuliano

Emilia Scalzulli

Mariadomenica Divona

...

2021/4

Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants

Blood cancer journal

Laura Cicconi

Anna Maria Testi

Pau Montesinos

Eduardo Rego

Hong Hu Zhu

...

2021/10/16

Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cells

Blood Cancer Journal

Serena Travaglini

Daniela Francesca Angelini

Valentina Alfonso

Gisella Guerrera

Serena Lavorgna

...

2020/8/25

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

Scientific reports

Carolina Hassibe Thomé

Germano Aguiar Ferreira

Diego Antonio Pereira-Martins

Guilherme Augusto Dos Santos

César Alexander Ortiz

...

2020/6/25

Reduced SLIT2 is associated with increased cell proliferation and arsenic trioxide resistance in acute promyelocytic leukemia

Cancers

Isabel Weinhäuser

Diego A Pereira-Martins

Cesar Ortiz

Douglas R Silveira

Luise AA Simoes

...

2020/10/27

Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty …

Haematologica

Luca Mazzarella

Edoardo Botteri

Anthony Matthews

Elena Gatti

Davide Di Salvatore

...

2020/6

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial

Blood Advances

Maria Teresa Voso

Richard A Larson

Dan Jones

Guido Marcucci

Thomas Prior

...

2020/10/13

WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine

Leukemia & Lymphoma

Giulia Falconi

Emiliano Fabiani

Tiziana Ottone

Alfonso Piciocchi

Serena Lavorgna

...

2020/3/20

Minimal Residual Disease in Leukemia

G Saglio

F Lo Coco

2020/8/26

Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial

Leukemia

Laura Cicconi

Uwe Platzbecker

Giuseppe Avvisati

Francesca Paoloni

Christian Thiede

...

2020/3

See List of Professors in francesco lo coco University(Università degli Studi di Roma Tor Vergata)